Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BG Medicine, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R15.htm
EX-32 - EX-32 - BG Medicine, Inc.d398643dex32.htm
EX-10.1 - EX-10.1 - BG Medicine, Inc.d398643dex101.htm
EX-31.2 - EX-31.2 - BG Medicine, Inc.d398643dex312.htm
EX-10.2 - EX-10.2 - BG Medicine, Inc.d398643dex102.htm
10-Q - FORM 10-Q - BG Medicine, Inc.d398643d10q.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R3.htm
EX-31.1 - EX-31.1 - BG Medicine, Inc.d398643dex311.htm
v2.4.0.6
Term Loan (Details) (USD $)
3 Months Ended 9 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Feb. 10, 2012
Feb. 01, 2012
Sep. 30, 2012
Common Stock Warrant Liability [Member]
Dec. 31, 2011
Common Stock Warrant Liability [Member]
Debt Instrument [Line Items]            
Purchase of common stock         36,657  
Term Loan (Textual) [Abstract]            
Loan facility     $ 15,000,000      
Initial funding     10,000,000      
Additional term loan 5,000,000 5,000,000   5,000,000    
Interest rate description   The initial term loan accrues interest at a rate of 8% per annum plus the higher of (a) the 3-month LIBOR rate or (b) 1.25%. Interest only payments will be made for the first twelve months of the loan term. Principal and interest payments commence in March 2013 and continue through maturity at September 2015.        
Term loan interest rate 8.00%          
LIBOR rate period 3-month LIBOR rate          
Term loan rate of interest for first twelve months   1.25%        
Principal and interest payments beginning date   Mar. 01, 2013        
Principal and interest payments maturity date   Sep. 01, 2015        
Exercise price of common stock 6.82 6.82        
Period of warrants   10 years     4 years 6 months 5 years 3 months 18 days
Fair value of common stock $ 8.51 $ 8.51     $ 3.68 $ 4.72
Volatility of common stock   70.00%       70.00%
Risk free interest rate   1.96%     0.55% 0.90%
Non cash interest due to relative fair value of warrants   240,000        
Cumulative product revenue   2,500,000        
Additional product revenue $ 2,100,000 $ 2,100,000